In familial LCAT deficiency (FLD) patients, intravenous administration of ACP-501, the recombinant human LCAT, improved the abnormal distribution of HDL subfractions and decreased TG levels after meals (126). This evidence concerns the gene NDUFAB1 and Familial LCAT deficiency.